Leerink Swann Upgrades Arena Pharmaceuticals (ARNA) to Outperform; Lorcaserin U.S. Partnership Announced
Tweet Send to a Friend
Leerink Swann upgrades Arena Pharmaceuticals (Nasdaq: ARNA) from Market Perform to Outperform. PT increased from $5 to $6
Leerink analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Leerink analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
